MatriQ and BGI-Research Sign Strategic Partnership to Advance Quantum Computing for Life Sciences
MatriQ and BGI-Research Sign Strategic Partnership to Advance Quantum Computing for Life Sciences
Hangzhou, October 22, 2026 — Hangzhou MatriQ Computing Co., Ltd. ("MatriQ") and BGI-Research (BGI Institute of Life Sciences) signed a strategic partnership agreement in Hangzhou. The signing ceremony was attended by Li Yuxiang, Chief Scientist at BGI-Research, and Zhang He, Director of the BGI-Research Hangzhou Branch, together with Xia Xiyuan, Founder and CEO of MatriQ, and Duan Shenghua, Head of Software at MatriQ.
Drawing on MatriQ's strengths in neutral-atom quantum computing and BGI-Research's expertise in life-science research, the two parties will collaborate on technology development and application validation at the intersection of quantum computing and life sciences (Q4Life), jointly exploring new pathways for a future "quantum computing + life sciences" industry.

MatriQ and BGI-Research sign the strategic partnership agreement
01
A Joint Laboratory for Quantum Bioinformatics,
a New Chapter for the Q4Life Industry
At the core of the partnership, the two parties will jointly establish a Quantum Bioinformatics Joint Laboratory. The laboratory will focus on common technical challenges at the intersection of quantum computing and life sciences, pursuing foundational technology research, quantum algorithm and tool development, and application validation in real-world scenarios, and will serve as a dedicated platform for long-term, cross-disciplinary research collaboration.
MatriQ will contribute the computing foundation, building on its neutral-atom quantum computers, quantum cloud platform and supporting algorithm development. BGI-Research will bring its multi-omics data resources, bioinformatics analysis capabilities and application scenarios to validate and deploy the results.
02
Quantum Computing × Life Sciences:
Starting from Real Applications and Needs
Addressing key computational scenarios and needs in the life sciences, the two teams have already held in-depth discussions on the first batch of collaborative projects. The initial focus is on applications such as genomics, exploring frontier directions including quantum optimization and quantum artificial intelligence, and studying hybrid approaches that combine quantum and classical computing. Working from concrete computational tasks, the teams will progressively develop quantum algorithms and tools tailored to practical application needs through algorithm design, experimental validation and performance evaluation.

Discussion session at the signing event
The strategic agreement marks the start of a long-term research collaboration between MatriQ and BGI-Research. Using the joint laboratory as the vehicle, the two parties will continue to combine their respective technologies and resources, deliver the first batch of collaborative projects, and organize joint research, technical exchange and cross-disciplinary talent development. Together they aim to drive breakthroughs in fundamental research and explore industrial applications at the intersection of quantum computing and life sciences, opening a quantum-driven path of innovation for the life and health industry.
MatriQ Secures Exclusive Strategic Investment from Fortune Capital to Accelerate Commercialization of Neutral-Atom Quantum Computing
2026/10/16
Selected as a “Treasure of the Expo”! MatriQ’s Full-Stack Neutral-Atom Quantum System Debuts at the Digital Trade Expo.
2026/09/29
Meet the AI Future at the Digital Trade Expo | MatriQ Invites You to the 5th Global Digital Trade Expo
2026/09/20